Prot #M16-415: A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Subjects with Metastatic Castrate Resistant Prostate Cancer (CRPC) and Relapsed/Refractory Acute Myeloid Leukemia (AML)

Project: Research project

Project Details

StatusActive
Effective start/end date9/27/189/27/22

Funding

  • AbbVie Inc. (Prot #M16-415)